The acquisition converts a lease liability into owned real estate but at a high cost, $49M at 15% interest alone implies ~$7.4M annual interest on the seller note. Monitor the next 10-Q for debt service coverage ratios and whether the facility's cash flow can support the combined interest burden. The two-year maturity on the seller note creates refinancing risk in 2027.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 1 $13.05entry
- T+1 · 6mo ago −3.15%α −3.30% · $12.64
- T+5 · 5mo ago −2.51%α +0.24% · $12.72
- T+20 · 5mo ago −23.47%α −22.17% · $9.99
- T+60 · 3mo ago −17.61%α −18.84% · $10.75
Price Chart
How similar events traded
Executive Summary
Vireo Growth exercised its purchase option to acquire a 389,000 sq ft cannabis cultivation facility in Perth, NY from an IIP subsidiary for $88.5M. The deal was funded by a $49M seller-financed note (15% interest, matures May 2027) and a $41M second-lien loan from Chicago Atlantic (prime + 5.75%, matures May 2028). The company now owns the facility free of lease obligations but carries $90M in new secured debt with aggressive interest costs.
Key Financial Metrics
Key Facts
- Acquired 389,000 sq ft cannabis cultivation facility in Perth, NY for $88.5M from IIP-NY 2 LLC (IIP subsidiary)
- Seller financing: $49M note at 15% interest, interest-only monthly, matures May 25, 2027, with two 1-year extension options (1% fee each)
- Chicago Atlantic loan: $41M at prime + 5.75%, matures May 28, 2028, second-priority lien subordinated to seller note
- Total new debt: $90M ($49M + $41M) secured by the property; company and subsidiary provide guarantees
- Previously leased facility, acquisition eliminates lease obligations but adds significant debt service burden
Financial Impact
$88.5M asset acquisition funded by $90M in new debt ($49M at 15% + $41M at prime+5.75%)
Risk Factors
- High interest cost ($49M at 15% + $41M at prime+5.75%) may strain cash flow
- Seller note matures May 2027, refinancing risk if cannabis credit markets tighten
- Cross-default provisions between the two loans could trigger acceleration
- Cannabis industry regulatory and federal illegality risks remain
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-068242 |
| Document: tm2615959d1_ex99-1.htm | 0001104659-26-068242 |
| Document: 0001104659-26-068242-index-headers.html | 0001104659-26-068242 |
| Document: 0001104659-26-068242-index.html | 0001104659-26-068242 |
| Document: 0001104659-26-068242.txt | 0001104659-26-068242 |
Track record
21 reports on VREOF
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +18.71% at T+60 after the Jun 18, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 3/10 Entry $6.13 Now $6.29 +2.68% settles Feb 11
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $6.13 Now $6.29 +2.68% settles Feb 11
- Nov 10, 20266d ago SC 13D/A Neutral 4/10 Entry $6.74 Now $6.29 −6.68% settles Feb 9
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $6.68 Now $6.29 −5.84% settles Feb 8
- Nov 3, 202614d ago EFFECT Neutral 4/10 Entry $7.45 Now $6.29 −15.57% settles Feb 1
- Oct 30, 202617d ago S-4/A Neutral 5/10 Entry $7.36 Now $6.29 −14.54% settles Jan 29
- Oct 9, 20265w ago S-4 Neutral 5/10 Entry $9.15 Now $6.29 −31.23% settles Jan 7
- Oct 8, 20265w ago 8-K Bullish 6/10 Entry $9.38 Now $6.29 −32.94% settles Jan 6
- Aug 18, 202612w ago 8-K Neutral 3/10 Entry $10.97 to $6.79 Now $6.29 −42.66% ▼ −38.10% −37.28% vs SPY
- Aug 11, 202613w ago 8-K Mixed 6/10 Entry $10.64 to $7.36 Now $6.29 −40.88% ▼ −30.83% −30.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers